PASADENA, CA / ACCESSWIRE / February 4, 2020 / De Novo Software, the premier provider of both research and clinical cytometry data analysis solutions, announced today that FCS Express™ will be bundled ...
HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley and Sons Inc. (NYSE:JWA) (NYSE:JWB), a global leader in research and education, today announced the acquisition of Bio-Rad Laboratories, Inc.’s Informatics ...
HERCULES, CA--(Marketwired - May 24, 2017) - Bio-Rad Laboratories, Inc. (NYSE: BIO) (NYSE: BIOb), a global provider of life science research and clinical diagnostic products, today announced that it ...
"Multiplex platforms produce a lot of data, and until now, customers lacked the appropriate tools to quickly draw conclusions from this exceptional amount of information," said Todd Yeck, Bio-Rad ...
Bio-Rad Laboratories, Inc. today announced the launch of its CFX Manager software version 3.1. Bio-Rad’s CFX Manager software is compatible with all CFX platforms and features optimized run files for ...
The CFX Opus 96 and CFX Opus 384 Real-Time PCR Systems represent the next generation of the company’s CFX Real-Time PCR Systems that are used in research and genomic testing as well as in pathogen ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) a global leader in life science research and clinical diagnostics products, today announced a collaboration agreement with Oncocyte Corporation (Nasdaq ...
Bio-Rad Laboratories has received FDA clearance for two digital PCR products designed to monitor patients’ molecular responses to tyrosine kinase inhibitor treatments in chronic myeloid leukemia. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback